| Glioma stem cells and their roles within the hypoxic tumor microenvironment NH Boyd, AN Tran, JD Bernstock, T Etminan, AB Jones, GY Gillespie, ... Theranostics 11 (2), 665, 2021 | 115 | 2021 |
| Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance E Cacan, MW Ali, NH Boyd, SB Hooks, SF Greer PloS one 9 (1), e87455, 2014 | 112 | 2014 |
| Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo NH Boyd, K Walker, J Fried, JR Hackney, PC McDonald, GA Benavides, ... JCI insight 2 (24), 2017 | 109 | 2017 |
| YAP/TAZ transcriptional coactivators create therapeutic vulnerability to verteporfin in EGFR-mutant glioblastoma K Vigneswaran, NH Boyd, SY Oh, S Lallani, A Boucher, SG Neill, JJ Olson, ... Clinical Cancer Research 27 (5), 1553-1569, 2021 | 76 | 2021 |
| NOS expression and NO function in glioma and implications for patient therapies AN Tran, NH Boyd, K Walker, AB Hjelmeland Antioxidants & redox signaling 26 (17), 986-999, 2017 | 55 | 2017 |
| Early epigenetic events regulate the adaptive immune response gene CIITA NT Mehta, AD Truax, NH Boyd, SF Greer Epigenetics 6 (4), 516-525, 2011 | 36 | 2011 |
| Chromodomain helicase DNA-binding protein 7 is suppressed in the perinecrotic/ischemic microenvironment and is a novel regulator of glioblastoma angiogenesis NH Boyd, K Walker, A Ayokanmbi, ER Gordon, J Whetsel, CM Smith, ... Stem Cells 37 (4), 453-462, 2019 | 22 | 2019 |
| The class II transactivator (CIITA) is regulated by post-translational modification cross-talk between ERK1/2 phosphorylation, mono-ubiquitination and Lys63 ubiquitination JE Morgan, RL Shanderson, NH Boyd, E Cacan, SF Greer Bioscience Reports 35 (4), e00233, 2015 | 16 | 2015 |
| Polycomb recruitment at the Class II transactivator gene NH Boyd, JE Morgan, SF Greer Molecular Immunology 67 (2), 482-491, 2015 | 15 | 2015 |
| Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose K Walker, NH Boyd, JC Anderson, CD Willey, AB Hjelmeland Biomarker Research 6, 1-9, 2018 | 14 | 2018 |
| Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. JCI Insight 2017; 2: 92928. c) Mastrolorenzo A, Rusconi S … NH Boyd, K Walker, J Fried, JR Hackney, PC McDonald, GA Benavides, ... Curr Med Chem 14 (2734), 48, 2007 | 8 | 2007 |
| Modeling physiologic microenvironments in three-dimensional microtumors maintains brain tumor initiating cells AN Gilbert, K Walker, AN Tran, NH Boyd, GY Gillespie, RK Singh, ... Journal of cancer stem cell research 5, 2017 | 5 | 2017 |
| RIOK2 drives glioblastoma cell proliferation by modulating MYC through the RNA-binding protein IMP3 AS Chen, J Marquez, NH Boyd, SY Oh, R Gulbronson, JAG Hamilton, ... bioRxiv, 2020.12. 07.413385, 2020 | 2 | 2020 |
| EXTH-27. YAP/TAZ TRANSCRIPTIONAL CO-ACTIVATORS CREATE THERAPEUTIC VULNERABILITY TO VERTEPORFIN IN EGFR MUTANT GLIOBLASTOMA R Read, K Vigneswaran, N Boyd, SY Oh, S Lallani, A Boucher, S Neill, ... Neuro-Oncology 22 (Suppl 2), ii92, 2020 | 1 | 2020 |
| Therapeutic targeting of the YAP/TAZ pathway in glioblastoma with verteporfin NH Boyd, K Vigneswaran, S Lallani, SY Oh, A Boucher, J Olson, R Read Cancer Research 80 (16_Supplement), 3789-3789, 2020 | 1 | 2020 |
| THE ROLE OF INSULIN-LIKE GROWTH FACTOR 2 BINDING PROTEIN 3 (IGF2BP3) AS A DRIVER OF TUMORIGENESIS IN GLIOBLASTOMA J Chow, A Chen, S Oh, E Young, N Boyd, R Read NEURO-ONCOLOGY 25, 2023 | | 2023 |
| DDDR-14. YAP/TAZ TRANSCRIPTIONAL CO-ACTIVATORS DRIVE NEURO-GLIAL STEM/PROGENITOR CELL IDENTITY IN HIGH GRADE GLIOMAS R Read, SY Oh, K Vigneswaran, N Boyd, E Young, W Read, J Olson Neuro-Oncology 24 (Suppl 7), vii101, 2022 | | 2022 |
| CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Glioblastoma Angiogenesis NH Boyd, K Walker, A Ayokanmbi, ER Gordon, J Whetsel, CM Smith, ... Stem cells (Dayton, Ohio) 37 (4), 453, 2019 | | 2019 |
| STEM CELLS 2019; 37: E7–E14 www. StemCells. com© AlphaMed Press 2019 BM Abdallah, D Aberdam, A Abu-Khader, S Acuna-Mendoza, ... Stem Cells 1119, 1125, 2019 | | 2019 |
| CHD7 IS SUPPRESSED IN THE PERINECROTIC/ISCHEMIC MICROENVIRONMENT AND IS A NOVEL REGULATOR OF ANGIOGENESIS N Boyd, A Ayokanmbi, K Walker, J Whetsel, J Gordillo, C Smith, E Gordon, ... NEURO-ONCOLOGY 20, 257-257, 2018 | | 2018 |
Kiera WalkerUniversity of Alabama at BirminghamVerified email at uab.edu
